Mario Suva
2Patents
0h-index
7Co-inventors
21Inventor score
Filing activity: Nov 13, 2018 → Nov 13, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12018080B2 | Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway | Emerging Cross-Sectional Technologies | 0 | Active |
| US12171783B2 | Methods and compositions for targeting developmental and oncogenic programs in H3K27M gliomas | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.